BN Business News
Add your company to Business Communicator →

Regulation & law · 29/11/2002Updated: 10/17/2026 · 1 min read

NIH Considers Exclusive License for Conjugate Vaccines Against Nontypeable Haemophilus Influenzae and Moraxella Catarrhalis

Summary

The National Institutes of Health is contemplating the grant of an exclusive license to Apovia, Inc. for the development of conjugate vaccines against diseases caused by nontypeable Haemophilus influenzae and Moraxella catarrhalis, particularly otitis media.

Original source language: Federal Register — All DocumentsOpen original release →

Explore insights

Business insights →